Current Treatment Landscape in First-line Urothelial Cancer

Download this slideset to review the latest data on immunotherapy for patients with newly diagnosed advanced urothelial carcinoma.
person default
Thomas Powles, MBBS, MRCP, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 462 KB
Released: September 21, 2020

Acknowledgements

Supported by an educational grant from
Pfizer and EMD Serono, Inc.

Related Content

Matthew Galsky, MD, discusses the evolving use of immunotherapy in urothelial carcinoma, from Clinical Care Options (CCO)

Matthew Galsky, MD Released: November 19, 2020

From Clinical Care Options (CCO), watch a short video with Kinjal Patel, PharmD, BCOP, reviewing new treatment options for patients with advanced or metastatic urothelial carcinoma

Kinjal Patel, PharmD, BCOP Susan Roethke, CRNP, MSN, AOCN, ANP-BC Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 13, 2020 Expired: November 12, 2021

Downloadable slides on immunotherapy for endometrial cancer from Clinical Care Options (CCO)

person default Mansoor Raza Mirza, MD Ana Oaknin, MD, PhD Released: November 12, 2020

Downloadable slides on molecular classification of ovarian cancer from Clinical Care Options (CCO)

person default Mansoor Raza Mirza, MD Ana Oaknin, MD, PhD Released: November 12, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue